Efficacy and safety of bortezomib in patients with renal impairment: results from the APEX phase 3 study - San-Miguel, Jesús F.; Richardson, P. G.; Sonneveld, P.; Schuster, M. W.; Irwin, D.; Stadtmauer, E. A.; Facon, T.; Harousseau, J.-L.; Ben-Yehuda, D.; Lonial, S.; Goldschmidt, Hartmut; Reece, D.; et al. (Leukemia, 2008)
Gesehen am 21.01.2022